Lynx1 Capital Management’s Neuphoria Therapeutics NEUP Stock Holding History

Lynx1 Capital Management’s Portfolio NEUP Stock Details NEUP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.56M	Buy	875,328 +100	+0%	+$423	0.56%	12
2025 Q4	$3.4M	Buy	+875,228	New	+$6.22M	0.69%	12
2025 Q3	–	Sell	-45,806	Closed	-$325K	–	17
2025 Q2	$325K	Hold	45,806	–	–	0.09%	13
2025 Q1	$264K	Hold	45,806	–	–	0.09%	13
2024 Q4	$157K	Hold	45,806	–	–	0.06%	17
2024 Q3	$241K	Sell	45,806 -4,167	-8%	-$33K	0.09%	14
2024 Q2	$460K	Sell	49,973 -17,899	-26%	-$195K	0.17%	12
2024 Q1	$839K	Sell	67,872 -820	-1%	-$10.8K	0.22%	15
2023 Q4	$1.22M	Buy	68,692 +733	+1%	+$20.9K	0.48%	13
2023 Q3	$2.2M	Buy	+67,959	New	+$1.46M	1.46%	12

Other funds holding NEUP

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Shay Capital New York $704M AUM 37.47% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Squadron Capital Management Westmont, Illinois $250M AUM

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return

FNY Investment Advisers New York $277M AUM 98.95% 1-Year Est. Return